369 results on '"Jern, S"'
Search Results
2. Valproic acid selectively increases vascular endothelial tissue‐type plasminogen activator production and reduces thrombus formation in the mouse
3. Valproic acid selectively increases endothelial, but not brain, t-PA production and reduces thrombus formation in mouse: OR380
4. Regression of electrocardiographic left ventricular hypertrophy predicts regression of echocardiographic left ventricular mass: the LIFE study
5. Association of left bundle branch block with left ventricular structure and function in hypertensive patients with left ventricular hypertrophy: the LIFE study
6. Obesity in adolescent men increases the risk of venous thromboembolism in adult life
7. Response to letter to editor by Jolobe ‘Results have relevance for resolving discrepancies in the approach to population screening’
8. Consistency of blood pressure and impact on cardiovascular structure over 20 years in young men
9. Impaired myocardial t-PA release in patients with coronary artery disease
10. Heterogeneous glycosylation patterns of human PAI-1 may reveal its cellular origin: O10–03
11. Local tissue-type plasminogen activator release in patients with ischemic stroke
12. TNF-α mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-κB- and p38 MAPK-dependent
13. Regulation of local availability of active tissue‐type plasminogen activator in vivo in man
14. Quantification of ADP and ATP receptor expression in human platelets
15. Systemic levels and preportal organ release of tissue-type plasminogen activator are enhanced by PEEP in the pig
16. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertension
17. Aortic cross-clamping influences regional net release and uptake rates of tissue-type plasminogen activator in pigs
18. Role of Histone Acetylation in the Stimulatory Effect of Valproic Acid on Vascular Endothelial Tissue-Type Plasminogen Activator Expression
19. Left bundle branch block and cardiovascular morbidity and mortality in hypertensive patients with left ventricular hypertrophy: the Losartan Intervention For Endpoint Reduction in Hypertension study
20. Regression of electrocardiographic left ventricular hypertrophy is associated with decreased incidence of new-onset diabetes mellitus hypertensive patients : The LIFE study
21. Effect of shear stress, statins and TNF-α on hemostatic genes in human endothelial cells
22. Interrelation of cardiac and vascular structure in young men with borderline hypertension
23. Letter to the Editor: Response to letter to editor by Jolobe ‘Results have relevance for resolving discrepancies in the approach to population screening’
24. Influence of TNF-α and biomechanical stress on endothelial anti- and prothrombotic genes
25. LETTER TO THE EDITOR
26. Effects of Two Complex Hemodynamic Stimulation Profiles on Hemostatic Genes in a Vessel-Like Environment
27. Mo-P2:202 The majority of plasminogen activator inhibitor 1 in platelets is functionally active
28. Tu-W19:3 Proinflammatory cytokine mediated T-PA suppression in vascular endothelial cells is NF-KAPPAB and P38 dependent
29. A novel computerized biomechanical perfusion system for ex vivo expression studies of artificial endothelial cell monolayer vessels
30. Mo-P2:187 Laminar shear stress suppresses the fibrinolytic capacity in cultured vascular endothelial cells
31. Regression of electrocardiographic left ventricle hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events
32. Break-through for calcium antagonists in the treatment of hypertension based on the Syst-Eur results
33. Comparison of effects of quinapril and metoprolol on glycaemic control, serum lipids, blood pressure, albuminuria and quality of life in non-insulin-dependent diabetes mellitus patients with hypertens
34. The enigmatic association of birth weight with blood pressure [editorial;comment]
35. Antihypertensive therapy--a viable branch of medicine [editorial]
36. Comparison of cardiovascular risk profile between male employees of twoautomotives companies in France and Sweden. The Coeur Project Group.
37. Unsatisfactory blood pressure control - Patient's neglect or doctor's hesitation?
38. Calcium antagonists - Looking stronger by the day
39. Is hypertension a risk factor for cancer?
40. Psychosocial factors and blood pressure. Why are nuns better off?
41. High capacity for tissue-type plasminogen activator release from vascular endothelium in vivo.
42. Hypertension research in the United Kingdom and Ireland--a source of inspiration.
43. Left ventricular hypertrophy--should it be looked for in all hypertensivepatients? [editorial]
44. Blood pressure--then and now [editorial]
45. Estrogen and progestagen modify the hemodynamic response to mental stress in young women
46. Prediction of insulin resistance [editorial; comment]
47. Smoking affects blood pressure [editorial]
48. What is happening to blood pressure? [editorial; comment]
49. Management of coexisting risk factors in hypertension--safe and sound?[editorial]
50. Risk reduction when treating hypertension - Are there differences between the various classes of drugs?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.